NBTX Competitors & Alternatives
Compare Nanobiotix with similar stocks in the same industry
Biotechnology
NBTX
Main Stock$29.19
Tradestie Score
45
Market Cap
$903.54M
Revenue Growth
-0.8%
Analyst Upside
+85.1%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$17.06
|
$1.42B | - | 49 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$13.57
|
$1.35B | - | 61 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.53
|
$1.32B | - | 54 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.86
|
$1.29B | - | 30 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$25.70
|
$1.29B | - | 51 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.20
|
$1.29B | - | 72 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.44
|
$1.28B | - | 35 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.70
|
$1.27B | - | 77 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
More NBTX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry